Express Healthcare10 小时
Cellogen Therapeutics secures patent for India’s first Bi-Specific CAR T Cell therapy
Cellogen Therapeutics’ CAR T cell technology introduces a bi-specific approach to cancer immunotherapy. Unlike conventional ...
Cellogen Therapeutics gets DCGI nod to develop indigenous Bi-Specific 3rd Generation CAR T ...
Our Bureau, Bengaluru Wednesday, March 19, 2025, 13:15 Hrs [IST] ...
Indiatimes20 小时
Natco Pharma Quarterly results
The Quarterly Results page of Natco Pharma Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.